RIYANKA PAUL

Employment

• Novo Nordisk AS Global Payer Evidence Generation Manager
  2022 - Present
• Complete HEOR Solutions India Pvt Ltd Associate manager
  2019 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Dose escalation of biologic therapies in biologic treatment-naive patients with Crohn’s disease: results from the ODESSA-CD study
  8th Annual IBD Horizons Pacific Northwest Symposium, 2023
  +Save
• Dose Escalation of Biologic Therapies in Biologic Treatment-Naïve Patients with Crohn’s Disease: Results from the ODESSA-CD Study
  American College of Gastroenterology (ACG) Annual Scientific meeting 2022
  +Save
• Economic Burden of Schizophrenia in the United States: A National Level Analysis
  2022
  +Save
• DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY
  Gastroenterology 2022 DOI: 10.1053/j.gastro.2021.12.025
  +Save
• DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY
  Inflammatory Bowel Diseases 2022 DOI: 10.1093/ibd/izac015.015
  +Save
• Comparison of Health-Related Quality of Life of Diabetic Adults with and without Cardiovascular Disease in the United States
  2021
  +Save